Inhibitors of ACC1 and FAS but not SCD1 decreased production of extracellular HBV DNA.
Products of FABS, long chain fatty acids, increased production of extracellular HBV DNA.
FAS inhibitor increased intracellular levels of HBV DNA and HBcAg.
FABS was suggested to contribute to HBV particle production without significant relation with secretory pathway of the cells.